ChemComm
Communication
Table 2 Substrate scope for the (R)-4 catalyzed enantioselective phospha-Michael addition of b,g-unsaturated a-ketoesters and amides 1 with
diarylphosphinesa
Entry
Substrate
R
R0
Ar
Time [h]
Product
Yieldb,c [%]
eed [%]
1
2
3
4
5
6
7
8
1a
1b
1c
1d
1e
1f
1g
1h
1i
1j
1k
1l
1a
1d
1i
1k
1aa
Ph
Ph
OMe
OiPr
OMe
OMe
OMe
OMe
OMe
OMe
OMe
OMe
OMe
OMe
OMe
OMe
OMe
OMe
NEt2
Ph
Ph
Ph
Ph
Ph
Ph
Ph
Ph
Ph
Ph
Ph
Ph
p-Tolyl
p-Tolyl
p-Tolyl
p-Tolyl
Ph
2.5
4
2a
2b
2c
2d
2e
2f
2g
2h
2i
98 (93)
98 (94)
98 (93)
98 (94)
98 (90)
99 (95)
98 (90)
98 (94)
98 (91)
93 (95)
90 (93)
94 (95)
98 (96)
499 (96)
98 (94)
499 (90)
95 (499)
81
83
83
85
85
87
90
89
71
78
84
65
66
71
70
75
70
p-FC6H4
p-ClC6H4
m-ClC6H4
p-BrC6H4
p-CF3C6H4
p-NO2C6H4
p-MeC6H4
p-MeOC6H4
m-Pyridyl
2-Thienyl
Ph
2.5
2.5
2.5
2.5
2.5
4
5
5
2
4
3.5
3.5
6
3.5
23
9
10
11
12
13
14
15
16
17
2j
2k
2l
2a0
2d0
2i0
2k0
2aa
p-ClC6H4
p-MeC6H4
m-Pyridyl
Ph
a
Reaction was carried out with Ar2PH (0.1 mmol) and 1 (0.1 mmol) in 3.6 mL of chloroform and 0.4 mL of dichloromethane. Solvents were degassed
prior to use. Yield is derived from the 31P{1H} NMR spectrum of the product. Values in parentheses indicate the abundance of keto tautomer 2
b
c
which is determined from the 31P{1H} NMR spectrum of the product. Enantiomeric excess (ee) is calculated from the 31P{1H} NMR integration
d
signals of diastereomers arising from the treatment of 2 and 3 with (R)-6.
Commun., 2010, 46, 6950–6952; ( f ) Y. Huang, R. J. Chew, Y. Li,
S. A. Pullarkat and P.-H. Leung, Org. Lett., 2011, 13, 5862–5865;
(g) R. J. Chew, Y. Huang, Y. Li, S. A. Pullarkat and P.-H. Leung,
Adv. Synth. Catal., 2013, 355, 1403–1408.
7 (a) C. A. Busacca, R. Raja, N. Grinberg, N. Haddad, P. James-Jones,
H. Lee, J. C. Lorenz, A. Saha and C. H. Sennanayake, J. Org. Chem.,
2008, 73, 1524–1531; (b) V. T. Trepohl, S. Mori, K. Itami and
M. Oestreich, Org. Lett., 2009, 11, 1091–1094.
8 For selected examples, see: (a) Z. Dong, J. Feng, X. Fu, X. Liu, L. Lin
and X. Feng, Chem. – Eur. J., 2011, 17, 1118–1121; (b) L. Gremaud
and A. Alexakis, Angew. Chem., Int. Ed., 2012, 51, 794–797.
9 (a) Y. D. Vankar, N. C. Chaudhuri and P. S. Vankar, J. Chem. Res., 1989,
6, 178–179; (b) Y. Hui, J. Jiang, W. Wang, W. Chen, Y. Cai, L. Lin, X. Liu
and X. Feng, Angew. Chem., Int. Ed., 2010, 49, 4290–4293.
centre in 1. Proton exchange followed by dissociation of the desired
product from the catalyst then completes the catalytic cycle. It
should be highlighted that 4 behaves purely as a Lewis acid catalyst
and thus palladium does not undergo any change in oxidation state
throughout the cycle. It is noteworthy that similar catalytic cycles
have recently been reported, resembling our proposed system.5
In conclusion, we have developed the first protocol involving
the catalytic enantioselective phospha-Michael addition of b,g-
unsaturated a-ketoesters and amides. Excellent yields of up
to 499% and enantioselectivities of up to 90% can be achieved
when coupled with low temperatures, which suppress the undesired
uncatalyzed pathway. The ease of access to such synthetically
important chiral tertiary phosphines greatly facilitates the prepara-
tion of catalytically versatile P,O and P,N bidentate ligands.
10 X. Xiong, C. Ovens, A. W. Pilling, J. W. Ward and D. J. Dixon,
Org. Lett., 2008, 10, 565–567.
11 J. Wang, P.-F. Li, S. H. Chan, A. S. C. Chan and F. Y. Kwong,
Tetrahedron Lett., 2012, 53, 2887–2889.
12 For selected examples, see: (a) J. Lv, X. Li, L. Zhong, S. Luo and
´
J.-P. Cheng, Org. Lett., 2010, 12, 1096–1099; (b) E. Sanchez-Larios,
K. Thai, F. Bilodeau and M. Gravel, Org. Lett., 2011, 13, 4942–4945;
(c) L. Liu, H. Ma, Y. Xiao, F. Du, Z. Qin, N. Li and B. Fu, Chem.
Commun., 2012, 48, 9281–9283; (d) D. Sinha, S. Perera and J. C. Zhao,
Chem. – Eur. J., 2013, 19, 6976–6979.
Notes and references
1 For selected examples, see: (a) W. Tang and X. Zhang, Chem. Rev.,
2003, 103, 3029–3070; (b) J. H. Xie, S. F. Zhu and Q. L. Zhou, Chem.
Rev., 2011, 111, 1713–1760.
2 For selected examples, see: (a) S. W. Smith and G. C. Fu, J. Am. Chem.
Soc., 2009, 131, 14231–14233; (b) A. Marinetti and A. Voituriez,
Synlett, 2010, 174–194.
3 K. M. Pietrusiewicz and M. Zablocka, Chem. Rev., 1994, 94, 1375–1411.
4 (a) D. K. Wicht, I. V. Kourkine, I. Kovacik and D. S. Glueck,
Organometallics, 1999, 18, 5381–5394; (b) I. Kovacik, D. K. Wicht,
N. S. Grewal and D. S. Glueck, Organometallics, 2000, 19, 950–953.
13 For selected examples, see: (a) L. Zhou, L. Lin, W. Wang, J. Ji, X. Liu and
X. Feng, Chem. Commun., 2010, 46, 3601–3603; (b) S. Goncalves-Contal,
L. Gremaud and A. Alexakis, Angew. Chem., Int. Ed., 2013, 52, 1–5.
14 For selected examples, see: (a) M. J. Johansson, S. Berglund, Y. Hu,
K. H. O. Andersson and N. Kann, ACS Comb. Sci., 2012, 14, 304–308;
(b) M. Rueping, B. J. Nachtsheim, S. A. Moreth and M. Bolte, Angew.
Chem., Int. Ed., 2008, 47, 593–596.
15 P.-H. Leung, Acc. Chem. Res., 2004, 37, 169–177.
5 (a) L. Rosenberg, ACS Catal., 2013, 3, 2845–2855; (b) V. Koshti, 16 K. Chen, S. A. Pullarkat, M. Ma, Y. Li and P.-H. Leung, Dalton Trans.,
S. Gaikwad and S. H. Chikkali, Coord. Chem. Rev., 2014, 265, 52–73. 2012, 41, 5391–5400.
6 (a) A. D. Sadow, I. Haller, L. Fadini and A. Togni, J. Am. Chem. Soc., 17 J. K.-P. Ng, G.-K. Tan, J. J. Vittal and P.-H. Leung, Inorg. Chem., 2003,
2004, 126, 14704–14705; (b) A. D. Sadow and A. Togni, J. Am. Chem. 42, 7674–7682.
Soc., 2005, 127, 17012–17024; (c) P. Butti, R. Rochat, A. D. Sadow and 18 See ESI†.
A. Togni, Angew. Chem., Int. Ed., 2008, 47, 4878–4881; (d) J. J. Feng, 19 CCDC 988281 contains the crystallographic data for compound (R,S)-9a.
X. F. Chen, M. Shi and W. L. Duan, J. Am. Chem. Soc., 2010, 132, 20 S. M. Chooi, S. Y. Siah, P. H. Leung and K. F. Mok, Inorg. Chem.,
5562–5563; (e) Y. Huang, S. A. Pullarkat and P.-H. Leung, Chem.
1993, 32, 4812–4818.
8770 | Chem. Commun., 2014, 50, 8768--8770
This journal is ©The Royal Society of Chemistry 2014